![Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinoma]()
Phase 1 study of everolimus and low-dose oral cyclophosphamide in patients with metastatic renal cell carcinomaHuijts, Charlotte M.; Werter, Inge M.; Lougheed, Sinéad M.; Goedegebuure, Ruben S.; van Herpen, Carla M.; Hamberg, Paul; Tascilar, Metin; Haanen, John B.; Verheul, Henk M.; de Gruijl, Tanja D.; van der Vliet, Hans J. · Cancer Immunology, Immunotherapy · 2018